ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
mcnamm
|
614 |
119K |
10 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
614
|
119K
|
10
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
mcnamm
|
614 |
119K |
15 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
614
|
119K
|
15
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Encouraging Initial Data from CYP-006TK DFU Trial
|
|
mcnamm
|
49 |
11K |
6 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
49
|
11K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
TA
|
|
mcnamm
|
20 |
5.6K |
4 |
24/02/24 |
24/02/24 |
ASX - By Stock
|
20
|
5.6K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Appendix 4D & Half-Year Financial Statements
|
|
mcnamm
|
1 |
862 |
13 |
24/02/24 |
24/02/24 |
ASX - By Stock
|
1
|
862
|
13
|
|
ASX - By Stock
|
CYP |
Re:
AGM voting
|
|
mcnamm
|
43 |
9.5K |
10 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
43
|
9.5K
|
10
|
|
ASX - By Stock
|
CYP |
Re:
AGM voting
|
|
mcnamm
|
43 |
9.5K |
8 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
43
|
9.5K
|
8
|
|
ASX - By Stock
|
CYP |
Re:
AGM voting
|
|
mcnamm
|
43 |
9.5K |
10 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
43
|
9.5K
|
10
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Phase 3 SCUlpTOR Osteoarthritis Clinical Trial Progress
|
|
mcnamm
|
6 |
1.8K |
13 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
6
|
1.8K
|
13
|
|
ASX - By Stock
|
CYP |
Re:
AGM voting
|
|
mcnamm
|
43 |
9.5K |
6 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
43
|
9.5K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
AGM voting
|
|
mcnamm
|
43 |
9.5K |
7 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
43
|
9.5K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
AGM voting
|
|
mcnamm
|
43 |
9.5K |
3 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
43
|
9.5K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
AGM voting
|
|
mcnamm
|
43 |
9.5K |
10 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
43
|
9.5K
|
10
|
|
ASX - By Stock
|
CYP |
AGM voting
|
|
mcnamm
|
43 |
9.5K |
11 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
43
|
9.5K
|
11
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Phase 3 Osteoarthritis Clinical Trial Commences
|
|
mcnamm
|
394 |
88K |
8 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
394
|
88K
|
8
|
|
ASX - By Stock
|
CYP |
Re:
Going forward...
|
|
mcnamm
|
2.1K |
704K |
14 |
23/01/23 |
23/01/23 |
ASX - By Stock
|
2.1K
|
704K
|
14
|
|
ASX - By Stock
|
CYP |
Re:
AGM Resolutions
|
|
mcnamm
|
115 |
19K |
2 |
04/11/21 |
04/11/21 |
ASX - By Stock
|
115
|
19K
|
2
|
|
ASX - By Stock
|
CYP |
AGM Resolutions
|
|
mcnamm
|
115 |
19K |
24 |
04/11/21 |
04/11/21 |
ASX - By Stock
|
115
|
19K
|
24
|
|
ASX - By Stock
|
CYP |
Re:
EGM campaign
|
|
mcnamm
|
75 |
19K |
2 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
75
|
19K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
EGM campaign
|
|
mcnamm
|
75 |
19K |
14 |
16/08/21 |
16/08/21 |
ASX - By Stock
|
75
|
19K
|
14
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Enrolled in Cynata MEND Clinical Trial
|
|
mcnamm
|
183 |
38K |
15 |
16/07/21 |
16/07/21 |
ASX - By Stock
|
183
|
38K
|
15
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Enrolled in Cynata MEND Clinical Trial
|
|
mcnamm
|
183 |
38K |
12 |
16/07/21 |
16/07/21 |
ASX - By Stock
|
183
|
38K
|
12
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Letter to Optionholders
|
|
mcnamm
|
237 |
35K |
19 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
237
|
35K
|
19
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata Technology Featured on Front Cover of Nature Medicine
|
|
mcnamm
|
184 |
33K |
4 |
18/11/20 |
18/11/20 |
ASX - By Stock
|
184
|
33K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Date of AGM & Closing Date for Director Nominations
|
|
mcnamm
|
44 |
10K |
9 |
13/10/20 |
13/10/20 |
ASX - By Stock
|
44
|
10K
|
9
|
|
ASX - By Stock
|
CYP |
Re:
CYP vs MSB
|
|
mcnamm
|
644 |
127K |
15 |
29/09/20 |
29/09/20 |
ASX - By Stock
|
644
|
127K
|
15
|
|
ASX - By Stock
|
CYP |
Re:
Wotton's Time is Now
|
|
mcnamm
|
69 |
37K |
19 |
18/08/20 |
18/08/20 |
ASX - By Stock
|
69
|
37K
|
19
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
mcnamm
|
507 |
1.5M |
5 |
25/06/20 |
25/06/20 |
ASX - By Stock
|
507
|
1.5M
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Appendix 3Y-Dr Geoff Brooke
|
|
mcnamm
|
5 |
2.2K |
3 |
24/06/20 |
24/06/20 |
ASX - By Stock
|
5
|
2.2K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval & Expedited Pathway for Phase 3 OA Trial
|
|
mcnamm
|
495 |
112K |
12 |
21/06/20 |
21/06/20 |
ASX - By Stock
|
495
|
112K
|
12
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Ethics Approval & Expedited Pathway for Phase 3 OA Trial
|
|
mcnamm
|
495 |
112K |
9 |
21/06/20 |
21/06/20 |
ASX - By Stock
|
495
|
112K
|
9
|
|
ASX - By Stock
|
CYP |
Re:
SPP chances of getting full allotment
|
|
mcnamm
|
86 |
23K |
15 |
27/05/20 |
27/05/20 |
ASX - By Stock
|
86
|
23K
|
15
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata MSCs beneficial in preclinical ARDS study
|
|
mcnamm
|
99 |
24K |
27 |
17/04/20 |
17/04/20 |
ASX - By Stock
|
99
|
24K
|
27
|
|
ASX - By Stock
|
CYP |
Re:
Stem cell injection for Cyp management
|
|
mcnamm
|
133 |
29K |
14 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
133
|
29K
|
14
|
|
ASX - By Stock
|
CYP |
Re:
Please explain
|
|
mcnamm
|
6 |
2.5K |
9 |
18/03/20 |
18/03/20 |
ASX - By Stock
|
6
|
2.5K
|
9
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
mcnamm
|
507 |
1.5M |
7 |
15/02/20 |
15/02/20 |
ASX - By Stock
|
507
|
1.5M
|
7
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
mcnamm
|
507 |
1.5M |
9 |
15/02/20 |
15/02/20 |
ASX - By Stock
|
507
|
1.5M
|
9
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
mcnamm
|
507 |
1.5M |
9 |
15/02/20 |
15/02/20 |
ASX - By Stock
|
507
|
1.5M
|
9
|
|
ASX - By Stock
|
CYP |
Re:
Mcnamm
|
|
mcnamm
|
28 |
22K |
29 |
15/02/20 |
15/02/20 |
ASX - By Stock
|
28
|
22K
|
29
|
|
ASX - By Stock
|
CYP |
Re:
Going forward...
|
|
mcnamm
|
2.1K |
704K |
13 |
17/12/19 |
17/12/19 |
ASX - By Stock
|
2.1K
|
704K
|
13
|
|
ASX - By Stock
|
CYP |
Re:
Going forward...
|
|
mcnamm
|
2.1K |
704K |
29 |
13/12/19 |
13/12/19 |
ASX - By Stock
|
2.1K
|
704K
|
29
|
|
ASX - By Stock
|
CYP |
Re:
Going forward...
|
|
mcnamm
|
2.1K |
704K |
5 |
12/12/19 |
12/12/19 |
ASX - By Stock
|
2.1K
|
704K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Going forward...
|
|
mcnamm
|
2.1K |
704K |
14 |
12/12/19 |
12/12/19 |
ASX - By Stock
|
2.1K
|
704K
|
14
|
|
ASX - By Stock
|
CYP |
Re:
Ann: CYP Files Application to Commence Phase 2 CLI Clinical Trial
|
|
mcnamm
|
35 |
18K |
6 |
25/11/19 |
25/11/19 |
ASX - By Stock
|
35
|
18K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
Wotton's Time is Now
|
|
mcnamm
|
69 |
37K |
7 |
24/11/19 |
24/11/19 |
ASX - By Stock
|
69
|
37K
|
7
|
|
ASX - By Stock
|
CYP |
Re:
Resolution seven - privacy or private company!?
|
|
mcnamm
|
78 |
91K |
13 |
19/11/19 |
19/11/19 |
ASX - By Stock
|
78
|
91K
|
13
|
|
ASX - By Stock
|
CYP |
Re:
Resolution seven - privacy or private company!?
|
|
mcnamm
|
78 |
91K |
12 |
19/11/19 |
19/11/19 |
ASX - By Stock
|
78
|
91K
|
12
|
|
ASX - By Stock
|
CYP |
Re:
Wotton's Time is Now
|
|
mcnamm
|
69 |
37K |
13 |
13/11/19 |
13/11/19 |
ASX - By Stock
|
69
|
37K
|
13
|
|
ASX - By Stock
|
CYP |
Re:
Wotton's Time is Now
|
|
mcnamm
|
69 |
37K |
16 |
13/11/19 |
13/11/19 |
ASX - By Stock
|
69
|
37K
|
16
|
|
ASX - By Stock
|
CYP |
Re:
Remuneration Report - Yeah or Nay ?
|
|
mcnamm
|
3 |
2.0K |
6 |
12/11/19 |
12/11/19 |
ASX - By Stock
|
3
|
2.0K
|
6
|
|